Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 804

1.

Inflammation and Depression: A Nervous Plea for Psychiatry to Not Become Immune to Interpretation.

Konsman JP.

Pharmaceuticals (Basel). 2019 Feb 14;12(1). pii: E29. doi: 10.3390/ph12010029. Review.

2.

Comparative Study of Two Oxidizing Agents, Chloramine T and Iodo-Gen®, for the Radiolabeling of β-CIT with Iodine-131: Relevance for Parkinson's Disease.

R Durante AC, V Sobral D, C Miranda AC, V de Almeida É, L Fuscaldi L, R F F de Barboza M, Malavolta L.

Pharmaceuticals (Basel). 2019 Feb 5;12(1). pii: E25. doi: 10.3390/ph12010025.

3.

Neurodegeneration with Brain Iron Accumulation Disorders: Valuable Models Aimed at Understanding the Pathogenesis of Iron Deposition.

Levi S, Tiranti V.

Pharmaceuticals (Basel). 2019 Feb 9;12(1). pii: E27. doi: 10.3390/ph12010027. Review.

4.

Curcumin and (-)- Epigallocatechin-3-Gallate Protect Murine MIN6 Pancreatic Beta-Cells Against Iron Toxicity and Erastin-Induced Ferroptosis.

Kose T, Vera-Aviles M, Sharp PA, Latunde-Dada GO.

Pharmaceuticals (Basel). 2019 Feb 6;12(1). pii: E26. doi: 10.3390/ph12010026.

5.

Camphor, Applied Epidermally to the Back, Causes Snout- and Chest-Grooming in Rats: A Response Mediated by Cutaneous TRP Channels.

Ishikawa DT, Vizin RCL, Souza CO, Carrettiero DC, Romanovsky AA, Almeida MC.

Pharmaceuticals (Basel). 2019 Feb 2;12(1). pii: E24. doi: 10.3390/ph12010024.

6.

Modulators of Transient Receptor Potential (TRP) Channels as Therapeutic Options in Lung Disease.

Dietrich A.

Pharmaceuticals (Basel). 2019 Feb 1;12(1). pii: E23. doi: 10.3390/ph12010023. Review.

7.

Correction: Mateusz, S., et al. Iron Supplementation in Suckling Piglets: An Ostensibly Easy Therapy of Neonatal Iron Deficiency Anemia. Pharmaceuticals 2018, 11, 128.

Szudzik M, Starzyński RR, Jończy A, Mazgaj R, Lenartowicz M, Lipiński P.

Pharmaceuticals (Basel). 2019 Jan 29;12(1). pii: E22. doi: 10.3390/ph12010022.

8.

On the Absolute Stereochemistry of Tolterodine: A Circular Dichroism Study.

Górecki M, Zullo V, Iuliano A, Pescitelli G.

Pharmaceuticals (Basel). 2019 Jan 26;12(1). pii: E21. doi: 10.3390/ph12010021.

9.

Identification of Potential Inhibitors from Pyriproxyfen with Insecticidal Activity by Virtual Screening.

Ramos RDS, Costa JDS, Silva RC, da Costa GV, Rodrigues ABL, Rabelo ÉM, Souto RNP, Taft CA, Silva CHTPD, Rosa JMC, Santos CBRD, Macêdo WJDC.

Pharmaceuticals (Basel). 2019 Jan 25;12(1). pii: E20. doi: 10.3390/ph12010020.

10.

TRPV1 Inhibits the Ventilatory Response to Hypoxia in Adult Rats, but Not the CO₂-Drive to Breathe.

Patrone LGA, Duarte JB, Bícego KC, Steiner AA, Romanovsky AA, Gargaglioni LH.

Pharmaceuticals (Basel). 2019 Jan 24;12(1). pii: E19. doi: 10.3390/ph12010019.

11.

[177Lu]Lu-PSMA-617 Salivary Gland Uptake Characterized by Quantitative In Vitro Autoradiography.

Tönnesmann R, Meyer PT, Eder M, Baranski AC.

Pharmaceuticals (Basel). 2019 Jan 24;12(1). pii: E18. doi: 10.3390/ph12010018.

12.

L-Ferritin: One Gene, Five Diseases; from Hereditary Hyperferritinemia to Hypoferritinemia-Report of New Cases.

Cadenas B, Fita-Torró J, Bermúdez-Cortés M, Hernandez-Rodriguez I, Fuster JL, Llinares ME, Galera AM, Romero JL, Pérez-Montero S, Tornador C, Sanchez M.

Pharmaceuticals (Basel). 2019 Jan 23;12(1). pii: E17. doi: 10.3390/ph12010017.

13.

Can the Efficacy of [18F]FDG-PET/CT in Clinical Oncology Be Enhanced by Screening Biomolecular Profiles?

O'Neill H, Malik V, Johnston C, Reynolds JV, O'Sullivan J.

Pharmaceuticals (Basel). 2019 Jan 23;12(1). pii: E16. doi: 10.3390/ph12010016. Review.

14.

Micellisation Mechanism and Behaviour of Soluplus®⁻Furosemide Micelles: Preformulation Studies of an Oral Nanocarrier-Based System.

Alopaeus JF, Hagesæther E, Tho I.

Pharmaceuticals (Basel). 2019 Jan 19;12(1). pii: E15. doi: 10.3390/ph12010015.

15.

Structural and In Vitro Functional Comparability Analysis of Altebrel™, a Proposed Etanercept Biosimilar: Focus on Primary Sequence and Glycosylation.

Fazel R, Guan Y, Vaziri B, Krisp C, Heikaus L, Saadati A, Nurul Hidayah S, Gaikwad M, Schlüter H.

Pharmaceuticals (Basel). 2019 Jan 17;12(1). pii: E14. doi: 10.3390/ph12010014.

16.

Cholecystokinin-2 Receptor Targeting with Novel C-terminally Stabilized HYNIC-Minigastrin Analogs Radiolabeled with Technetium-99m.

Klingler M, Rangger C, Summer D, Kaeopookum P, Decristoforo C, von Guggenberg E.

Pharmaceuticals (Basel). 2019 Jan 15;12(1). pii: E13. doi: 10.3390/ph12010013.

17.

Optimization of the Automated Synthesis of [11C]mHED-Administered and Apparent Molar Activities.

Vraka C, Pichler V, Berroterán-Infante N, Wollenweber T, Pillinger A, Hohensinner M, Fetty L, Beitzke D, Li X, Philippe C, Pallitsch K, Mitterhauser M, Hacker M, Wadsak W.

Pharmaceuticals (Basel). 2019 Jan 14;12(1). pii: E12. doi: 10.3390/ph12010012.

18.

The Therapeutic Potential of Naringenin: A Review of Clinical Trials.

Salehi B, Fokou PVT, Sharifi-Rad M, Zucca P, Pezzani R, Martins N, Sharifi-Rad J.

Pharmaceuticals (Basel). 2019 Jan 10;12(1). pii: E11. doi: 10.3390/ph12010011. Review.

19.

Juvenile Arthritis Patients Suffering from Chronic Inflammation Have Increased Activity of Both IDO and GTP-CH1 Pathways But Decreased BH4 Efficacy: Implications for Well-Being, Including Fatigue, Cognitive Impairment, Anxiety, and Depression.

Korte-Bouws GAH, Albers E, Voskamp M, Hendriksen H, de Leeuw LR, Güntürkün O, de Roock S, Vastert SJ, Korte SM.

Pharmaceuticals (Basel). 2019 Jan 8;12(1). pii: E9. doi: 10.3390/ph12010009.

20.

The Multi-Functional Calcium/Calmodulin Stimulated Protein Kinase (CaMK) Family: Emerging Targets for Anti-Cancer Therapeutic Intervention.

Brzozowski JS, Skelding KA.

Pharmaceuticals (Basel). 2019 Jan 7;12(1). pii: E8. doi: 10.3390/ph12010008. Review.

Supplemental Content

Loading ...
Support Center